Androgen receptor signaling affects response to targeted therapy in people with melanoma

By | June 15, 2022
Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today in Nature.